Alkermes (ALKS) Share-based Compensation Growth (5y) (2015 - 2026)
Alkermes (ALKS) Share-based Compensation Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.04% |
| Mar 31, 2026 | 50.24% |
| Dec 31, 2025 | 1.09% |
| Sep 30, 2025 | -51.26% |
| Jun 30, 2025 | 45.35% |
| Mar 31, 2025 | 57.25% |
| Dec 31, 2024 | -0.60% |
| Sep 30, 2024 | -27.05% |
| Jun 30, 2024 | 4.88% |
| Mar 31, 2024 | 1.24% |
| Dec 31, 2023 | 8.61% |
| Sep 30, 2023 | -0.94% |
| Jun 30, 2023 | 18.93% |
| Mar 31, 2023 | -26.24% |
| Dec 31, 2022 | -30.66% |
| Sep 30, 2022 | 5.98% |
| Jun 30, 2022 | -6.51% |
| Mar 31, 2022 | -38.95% |
| Dec 31, 2021 | -0.78% |
| Sep 30, 2021 | 1.53% |